A company that spent 25 years making eye drops just walked away from pharmaceuticals entirely to go all-in on crypto. NovaBay Pharmaceuticals announced on March 23 that it will rebrand as Stablecoin Development Corporation, shifting completely from its healthcare roots to become an on-chain holding company focused on digital assets.Shares jumped nearly 19% to roughly $1.38 on the news, as the company disclosed holdings of approximately two billion SKY tokens.This is a major signal. When legacy companies abandon their core business to build a crypto treasury, the narrative around digital assets as long-term infrastructure has clearly crossed a threshold.If you’re scanning for the best crypto to buy now, the most asymmetric opportunity may well be DeepSnitch AI. Their presale closes on March 31.From eye drops to stablecoins: Why NovaBay’s pivot changes the storyIn January 2026, NovaBay entered into a $134 million private placement backed by Tether Investments, using the proceeds to adopt an “on-chain holding company framework focused on long-duration participation in protocol-level digital asset ecosystems.”The company has since acquired more than two billion SKY tokens on the open market and has generated 26.6 million SKY tokens in cumulative staking rewards. SKY was trading at $0.071 as of March 24.NovaBay’s announcement comes just as stablecoins are the center of attention for investors and policymakers. Lawmakers have apparently reached an agreement in principle on how stablecoin yield should be handled under a broader crypto market structure bill.The bull case is straightforward: when a public company can make a move like this and communicate it to shareholders without being laughed at, traditional finance’s relationship with crypto has fundamentally shifted.That shift matters for every new crypto opportunity in the market right now. Capital rotating from legacy industries into digital assets creates the kind of broad demand environment where early-stage projects with real utility, like DeepSnitch AI, can move fast.Is DeepSnitch AI the best crypto to buy now?Most retail investors lose money in crypto, not because they chose the wrong chain or missed a macro trend. They lose because they can’t screen out fraud fast enough.DeepSnitch AI addresses that problem directly, with five fully operational AI agents available on its live dashboard today, with massive potential to reach a broad base of retail traders and investors. The March 31st presale window is about to close, and some community projections see the DSNT token doing a 300X post-launch.While estimates are to be taken with a pinch of salt, the structural argument is real: a live product, a massive addressable market in retail fraud protection, and an AI sector tailwind that isn’t going away.The presale has now crossed $2.4 million raised, and it is currently priced at $0.04669 in Stage 8 of 15. RENDER price prediction: Decentralized GPU computing finds its momentRender Network is the clearest infrastructure play for the AI computing boom. The protocol connects GPU owners with creators and developers who need rendering power for AI inference, 3D animation, and machine learning workloads. It is essentially a decentralized alternative to the cloud computing giants. As AI model training and inference demand keep climbing, the case for a distributed GPU marketplace gets stronger.RENDER was priced at $1.76 on March 24. Price predictions in 2026 range between $6.00 and $15.00, with the trajectory dependent on AI adoption rates, overall market conditions, and sustained network usage growth.That’s a wide range that honestly reflects where RENDER sits today: the narrative is good, and the utility is real, but price recovery depends on a broader altcoin turn.RENDER can stake a claim for being a decent investment, but possibly not the best crypto for long-term investment. Even a best-case $15 valuation in 2026, the growth story is only 8-9X. At current prices, it is a project that the broader market already knows about, and the price largely reflects this.INJ price prediction: Injective positions itself as DeFi’s execution layerInjective has spent most of 2025 and early 2026 significantly below its 2024 peak, but the underlying build has continued. The protocol is reinventing itself as a financial execution layer, built for derivatives, real-world assets, and institutional-grade trading. A Community Buyback program launched in January 2026 now uses protocol revenue to purchase INJ from the open market, burning a portion and rewarding active stakers with the rest.Around half of the INJ token supply is being staked, which generally means the price reacts more sharply when new demand comes in.CoinPedia projects INJ could hit $15.40 by the end of 2026 and $28.90 by the end of 2027. The honest picture is that INJ is a recovery trade, not a momentum trade right now. Whether it delivers depends on whether its RWA and derivatives thesis gets validated before the broader market moves on.RENDER and INJ are decent plays for investors looking at breakout altcoins with strong narratives heading into the second half of 2026. However, it’s questionable whether either will experience a major breakout in 2026.The bigger picture: Legacy capital is choosing cryptoThe NovaBay pivot fits a clear pattern. It adds to a wave of companies over the last year that have pivoted to a crypto strategy, using treasury allocation and protocol participation to drive returns that their original business models could no longer match.RENDER and INJ both stand to benefit from this wave as capital seeks out established infrastructure tokens with real usage. Both are decent buys, but it’s unlikely either is the best crypto to buy now. The crown may belong to DeepSnitch AI.After March 31, the token will list on Uniswap, and the presale price will disappear permanently. There’s a seven-day claiming window post-close to activate staking before the token goes live. VIP bonus codes are still active, adding extra DSNT depending on purchase size.The wave of legacy capital entering crypto is confirmed. The question is whether you enter before or after it reprices the market. Visit the official DeepSnitch AI presale before March 31.Frequently asked questionsWhat are the best new crypto opportunities in March 2026?DeepSnitch AI stands out among the pack and may be the best new crypto opportunity right now. It has a live product with five working AI tools with over $2.4M already raised. Among established tokens, RENDER and INJ both offer credible 2026 cases, but it’s questionable whether either of them is the best crypto to buy now.Why did NovaBay Pharmaceuticals rebrand to Stablecoin Development Corporation?The company cited stablecoins as one of the biggest opportunities in the world of finance. This change is part of a broader move to a more crypto-friendly environment, a trend that will benefit fast-growing altcoins like DeepSnitch AI.The company pivoted entirely from healthcare to crypto after closing a $134 million private placement and acquiring over 2 billion SKY tokens. Management cited stablecoins as the most compelling structural opportunity in digital finance, well ahead of anything its pharmaceutical business was generating.Is RENDER a good long-term crypto investment?RENDER has utility as a decentralized GPU infrastructure for AI and 3D rendering workloads, putting it in a category that grows as AI demand scales. Price predictions for 2026 range from $6 to $15, depending on adoption momentum and broader market conditions. It may be a decent long-term hold, but the best crypto to buy now may be DeepSnitch AI.The post Best Crypto to Buy Now for Q2 Gains: RENDER and INJ Could Run, but DeepSnitch AI Is the Altcoin That Can Offer Exponential Growth appeared first on Blockonomi.